Back to Investors

Propela Ventures

Evidence PackPROIndependent
Private EquityLondon, UK Website
AUM
Ownership
independent
Stakeability
Not scored
Priority
Tier 3
Employees
5

Propela Ventures is a real estate seeding platform that partners with private family offices in direct real estate strategies. They provide seed capital and institutional know-how to create professional, digitally-enhanced, and scalable operating platforms in high growth sectors (later living, student housing, BTR, hospitality, self storage, data centres) across the UK and Europe. They bridge the funding gap to 50m GBP/EUR GAV, attracting the next phase of institutional growth capital.

SEC RegisteredFund PerformanceBDC ExposureTeam DataRegulatory

Coverage

42%

Adaptive profile: standard

Signals present
5/12
SEC / ADVFund Performance(50)BDC Exposure(4)13F Holders(0)Team(30)ILS Deals(0)Regulatory(16)Legal(0)Lobbying(0)Hiring(0)News(0)GP Stakes Deals(0)

Data Freshness

Recent Changes

Unable to load signal breakdown.

IC Risk Memo

PRO

Investment committee-ready memo with risk analysis and recommendation

Click "Generate Memo" to create an IC-ready analysis

Includes risk factors, citations, and recommendation

CRD Number
160395
SEC File Number
801-120173
Registration Type
Registered
Filing Date
Apr 23, 2025
Employee Count
N/A
Discretionary AUM
$1.3B
Private Funds
12
PE Funds
2
VC Funds
9
RE Funds
N/A
Hedge Funds
1
Gross Assets (Private)
$1.3B
Source: SEC IAPD

Fund performance data requires Professional

Upgrade your plan to access this section.

Upgrade

BDC exposure data requires Professional

Upgrade your plan to access this section.

Upgrade

Team data requires Professional

Upgrade your plan to access this section.

Upgrade

Team intelligence requires Professional

Upgrade your plan to access this section.

Upgrade

Competition mapping requires Professional

Upgrade your plan to access this section.

Upgrade

Regulatory data requires Professional

Upgrade your plan to access this section.

Upgrade

No GP stakes deals recorded

This GP has not sold a minority stake, making it a potential target.